2026 Brivaracetam market price and price trend reference
Brivaracetam/Brivaracetam, as a new type of anti-epileptic drug, has been marketed in many countries and regions and is mainly used to treat partial epileptic seizures. Brivaracetam is not currently on the market in mainland China, so domestic patients are not yet able to purchase this drug through formal channels. In overseas markets, Brivaracetam is already on the market, and its price will vary according to different markets and drug manufacturers.
In the European market, the specification of the original drug of Brivaracetam is50mg*60 tablets, and the price per box is about RMB 4,000. Because Brivaracetam is an innovative drug, its price is usually higher. Drug prices are also affected by various factors such as exchange rate fluctuations and import and export fees, so the actual purchase price may fluctuate.

In addition, there are currently no generic versions of Brivaracetam on the overseas market. Although the emergence of generic drugs in the drug markets of other countries usually brings about price reductions, generic drugs of Brivaracetam have not yet been put on the market due to its special pharmacological effects and therapeutic needs. This also means that patients can only choose to buy original drugs, which are more expensive.
The price of brivaracetam may fluctuate as market supply and demand change. Considering that brivaracetam is a relatively new anti-epileptic drug and is currently produced by only a few companies, its price may remain high in the short term. However, it is possible that prices will gradually decrease over time and possibly as generics become available. In addition, drug pricing is also closely related to factors such as the dosage of the drug used by the patient and the duration of treatment.
Brivaracetam is currently not approved for marketing in China and therefore cannot be included in domestic medical insurance. If patients need to use this drug, they may need to purchase it through imported channels and bear the full cost. In other countries, Brivaracetam may be reimbursed according to local health insurance policies, but reimbursement may vary by country and region.
Reference materials:https://www.briviact.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)